Search Results 11-20 of 19608 for Receptor
Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR- ...
CAR-T cell therapy stands for chimeric antigen receptor (CAR)-T cell therapy. This treatment falls under the category of immunotherapy. Immunotherapy for ...
Orexin Receptor Antagonist in Hospitalized Patients With Cancer to Prevent Delirium · Overview · Participation eligibility · Participating Mayo Clinic locations.
The purpose of this study is establish the highest dose of Q702 tested that has acceptable tolerability and safety. Participation eligibility. Participant ...
A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women · Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...
... receptor-T cell therapy featured image. Biotherapeutics. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla ...
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-. Cancer. Researchers seek to improve success of chimeric antigen ...
It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This ...
The purpose of this research study is to determine whether an ex vivo analysis of CCK receptor function when this receptor is expressed on buffy coat cells is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.